SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950144-09-002903
Filing Date
2009-04-03
Accepted
2009-04-03 11:58:57
Documents
4
Period of Report
2009-04-30
Effectiveness Date
2009-04-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A g18284def14a.htm DEF 14A 668324
2 GRAPHIC g18284g1828400.gif GRAPHIC 2298
3 GRAPHIC g18284g1828401.jpg GRAPHIC 257061
4 GRAPHIC g18284g1828402.jpg GRAPHIC 199081
  Complete submission text file 0000950144-09-002903.txt   1301855
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 09730831
SIC: 2836 Biological Products, (No Diagnostic Substances)